Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 2 mg | $39 | - | In Stock |
| Description | TrkA-IN-4 is a highly potent, orally active TrkA allosteric inhibitor that is metabolized in vivo as a prodrug to its active form, TrkA-IN-3. TrkA-IN-4 has demonstrated effective anti-injury effects. |
| In vivo | TrkA-IN-4 (0.9375-120 mg/kg; i.g.) exhibits stronger maximum antinociceptive effects 3 h after administration, with an ED50 of 7.836 mg/kg in hot plate testing on male mice.[1] |
| Molecular Weight | 538.48 |
| Formula | C27H21F3N4O5 |
| Cas No. | 3026111-74-7 |
| Smiles | FC(F)(F)C1=C(C2=NN(C)C=C2)C=C(C(NC3=C(C4=CC=CC=C4)N=CC(C(OCOC(C)=O)=O)=C3)=O)C=C1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 40 mg/mL (74.28 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.